Net profit of Alembic Pharmaceuticals declined 11.96% to Rs 156.89 crore in the quarter ended March 2025 as against Rs 178.21 crore during the previous quarter ended March 2024. Sales rose 16.66% to Rs 1769.64 crore in the quarter ended March 2025 as against Rs 1516.98 crore during the previous quarter ended March 2024.
For the full year,net profit declined 5.26% to Rs 583.42 crore in the year ended March 2025 as against Rs 615.82 crore during the previous year ended March 2024. Sales rose 7.12% to Rs 6672.08 crore in the year ended March 2025 as against Rs 6228.63 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 1769.64 | 1516.98 | 17 | 6672.08 | 6228.63 | 7 |
| OPM % | 15.33 | 17.12 | - | 15.11 | 14.97 | - |
| PBDT | 260.94 | 252.33 | 3 | 972.88 | 904.50 | 8 |
| PBT | 191.95 | 182.85 | 5 | 694.30 | 631.83 | 10 |
| NP | 156.89 | 178.21 | -12 | 583.42 | 615.82 | -5 |